Portfolio Holdings Detail for ISIN IE00BL3J3G74
Stock Name / Fund iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CSPXx(MXN) CXE

Holdings detail for EW

Stock Name	Edwards Lifesciences Corp
Ticker	EW(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US28176E1082
LEI	YA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen: Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings: Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab: Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW): Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research: Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00: Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW): J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW): Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC: Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW): Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares Core S&P 500 UCITS ETF MXN Hedged (Acc) EW holdings

Date	Number of EW Shares Held	Base Market Value of EW Shares	Local Market Value of EW Shares	Change in EW Shares Held	Change in EW Base Value	Current Price per EW Share Held	Previous Price per EW Share Held
2025-09-29 (Monday)	1,391,606	USD 107,418,067	USD 107,418,067
2025-09-26 (Friday)	1,390,868	USD 106,053,685	USD 106,053,685
2025-09-25 (Thursday)	1,389,968	USD 104,622,891	USD 104,622,891	1,148	USD 933,590	USD 75.27	USD 74.66
2025-09-24 (Wednesday)	1,388,820	USD 103,689,301	USD 103,689,301
2025-09-18 (Thursday)	1,384,556	USD 103,218,650	USD 103,218,650	82	USD -893,795	USD 74.55	USD 75.2
2025-09-17 (Wednesday)	1,384,474	USD 104,112,445	USD 104,112,445	738	USD 207,709	USD 75.2	USD 75.09
2025-09-16 (Tuesday)	1,383,736	USD 103,904,736	USD 103,904,736
2025-09-15 (Monday)	1,383,408	USD 105,208,178	USD 105,208,178
2025-09-12 (Friday)	1,382,588	USD 107,247,351	USD 107,247,351

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE00BL3J3G74

Show aggregate share trades of EW

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-25 BUY 1,148 75.270* 72.94
2025-09-18 BUY 82 74.550* 72.93
2025-09-17 BUY 738 75.200* 72.91
2025-09-11 BUY 410 78.010* 72.88
2025-09-09 BUY 410 79.800* 72.81
2025-07-24 BUY 82 75.800* 72.79
2025-07-23 BUY 492 76.910* 72.77
2025-07-22 BUY 738 76.300* 72.74
2025-07-21 BUY 164 76.560* 72.72
2025-07-18 SELL -820 76.490* 72.70 Profit of 59,612 on sale
2025-07-17 BUY 82 76.180* 72.68
2025-07-16 BUY 328 76.140* 72.65
2025-07-15 SELL -1,245 76.810* 72.63 Profit of 90,422 on sale
2025-07-14 BUY 656 78.280* 72.59
2025-07-11 SELL -164 78.050* 72.56 Profit of 11,899 on sale
2025-07-10 BUY 656 78.800* 72.52
2025-07-09 BUY 656 77.190* 72.49
2025-07-08 BUY 492 76.390* 72.46
2025-07-07 SELL -1,886 76.690* 72.43 Profit of 136,611 on sale
2025-07-02 SELL -2,378 77.020* 72.35 Profit of 172,037 on sale
2025-06-30 BUY 1,394 78.210* 72.31
2025-06-27 BUY 738 78.210* 72.27
2025-06-25 SELL -164 76.970* 72.20 Profit of 11,841 on sale
2025-06-24 BUY 82 75.850* 72.18
2025-06-23 BUY 2,132 75.320* 72.15
2025-06-18 SELL -492 73.980* 72.13 Profit of 35,487 on sale
2025-06-13 SELL -246 75.150* 72.08 Profit of 17,731 on sale
2025-06-12 BUY 246 75.890* 72.05
2025-06-11 BUY 328 75.470* 72.03
2025-06-06 SELL -410 77.520* 71.92 Profit of 29,489 on sale
2025-06-05 SELL -246 77.770* 71.88 Profit of 17,683 on sale
2025-06-04 SELL -328 77.850* 71.84 Profit of 23,562 on sale
2025-06-02 BUY 1,066 78.100* 71.74
2025-05-30 SELL -237 78.220* 71.69 Profit of 16,991 on sale
2025-05-29 BUY 82 77.730* 71.64
2025-05-28 SELL -81 76.660* 71.60 Profit of 5,800 on sale
2025-05-27 BUY 902 76.220* 71.57
2025-05-23 SELL -1,640 74.990* 71.51 Profit of 117,281 on sale
2025-05-22 SELL -1,804 74.790* 71.49 Profit of 128,961 on sale
2025-05-21 BUY 82 76.100* 71.45
2025-05-20 BUY 656 77.830* 71.40
2025-05-19 BUY 2,378 78.040* 71.34
2025-05-16 BUY 2,214 78.000* 71.28
2025-05-15 BUY 1,804 76.880* 71.24
2025-05-14 BUY 1,640 76.750* 71.19
2025-05-13 SELL -328 75.500* 71.15 Profit of 23,338 on sale
2025-05-12 BUY 82 74.800* 71.12
2025-05-09 BUY 246 73.680* 71.10
2025-05-08 SELL -2,378 74.630* 71.07 Profit of 168,998 on sale
2025-05-07 SELL -1,148 75.040* 71.03 Profit of 81,545 on sale
2025-05-06 BUY 2,870 74.920* 71.00
2025-05-02 BUY 246 75.650* 70.92
2025-05-01 SELL -410 75.180* 70.88 Profit of 29,060 on sale
2025-04-30 BUY 246 75.490* 70.83
2025-04-29 BUY 574 76.280* 70.78
2025-04-28 BUY 1,224 75.540* 70.74
2025-04-25 BUY 1,148 76.040* 70.69
2025-04-24 BUY 328 75.130* 70.64
2025-04-23 BUY 902 70.460* 70.64
2025-04-22 SELL -498 70.600* 70.65 Profit of 35,181 on sale
2025-04-17 BUY 164 71.530* 70.63
2025-04-16 BUY 7,784 71.200* 70.62
2025-04-15 BUY 1,640 70.760* 70.62
2025-04-11 BUY 2,050 69.400* 70.64
2025-04-10 BUY 3,362 68.260* 70.67
2025-04-09 BUY 656 69.900* 70.67
2025-04-08 BUY 1,722 67.070* 70.71
2025-04-07 BUY 1,964 69.000* 70.73
2025-04-04 SELL -4,920 69.360* 70.75 Profit of 348,079 on sale
2025-04-02 BUY 574 72.050* 70.73
2025-03-31 SELL -2,214 72.480* 70.70 Profit of 156,530 on sale
2025-03-28 SELL -1,394 70.910* 70.70 Profit of 98,552 on sale
2025-03-27 SELL -410 71.190* 70.69 Profit of 28,984 on sale
2025-03-26 BUY 738 71.090* 70.69
2025-03-25 SELL -984 71.240* 70.68 Profit of 69,549 on sale
2025-03-24 BUY 574 71.350* 70.67
2025-03-21 BUY 984 70.460* 70.67
2025-03-19 BUY 152 70.900* 70.67
2025-03-18 SELL -1,476 70.340* 70.67 Profit of 104,313 on sale
2025-03-17 BUY 1,558 70.630* 70.67
2025-03-14 BUY 1,394 69.290* 70.69
2025-03-13 BUY 6,876 67.950* 70.73
2025-03-12 BUY 3,280 68.510* 70.76
2025-03-11 BUY 1,312 68.390* 70.79
2025-03-07 BUY 778 70.330* 70.83
2025-03-06 SELL -738 71.800* 70.81 Profit of 52,261 on sale
2025-03-05 BUY 2,554 72.850* 70.79
2025-03-04 BUY 492 71.380* 70.78
2025-03-03 BUY 2,214 71.390* 70.77
2025-02-28 SELL -574 71.620* 70.75 Profit of 40,613 on sale
2025-02-27 BUY 82 71.400* 70.74
2025-02-26 SELL -164 71.960* 70.73 Profit of 11,599 on sale
2025-02-25 BUY 1,558 71.450* 70.71
2025-02-21 BUY 1,148 73.300* 70.64
2025-02-20 BUY 656 74.710* 70.57
2025-02-19 BUY 164 74.670* 70.50
2025-02-18 BUY 410 75.670* 70.41
2025-02-13 BUY 1,394 76.000* 70.10
2025-02-12 BUY 492 75.820* 69.99
2025-02-11 SELL -164 70.910* 69.98 Profit of 11,476 on sale
2025-02-07 SELL -656 70.350* 69.95 Profit of 45,885 on sale
2025-02-06 BUY 328 70.990* 69.93
2025-02-04 BUY 2,870 71.330* 69.85
2025-02-03 BUY 1,066 71.380* 69.82
2025-01-31 BUY 246 72.450* 69.76
2025-01-30 BUY 164 73.220* 69.69
2025-01-29 BUY 1,558 71.130* 69.65
2025-01-28 BUY 738 72.560* 69.58
2025-01-27 BUY 1,148 69.200* 69.59
2025-01-24 BUY 738 68.990* 69.61
2025-01-23 BUY 2,132 68.930* 69.63
2025-01-02 BUY 2,673 72.590* 69.55
2024-12-30 SELL -7,630 74.240* 69.43 Profit of 529,723 on sale
2024-12-10 BUY 588 73.390* 69.32
2024-12-09 BUY 672 70.900* 69.28
2024-12-06 BUY 1,008 71.530* 69.21
2024-12-05 BUY 252 72.430* 69.12
2024-12-04 BUY 924 74.200* 68.96
2024-12-03 BUY 2,964 70.200* 68.92
2024-12-02 BUY 247 70.530* 68.87
2024-11-29 BUY 1,909 71.350* 68.79
2024-11-27 BUY 2,241 72.070* 68.55
2024-11-26 BUY 4,814 71.550* 68.44
2024-11-25 BUY 4,980 71.270* 68.33
2024-11-22 BUY 5,880 70.480* 68.25
2024-11-21 BUY 924 70.380* 68.16
2024-11-20 BUY 840 69.540* 68.10
2024-11-19 BUY 756 70.200* 68.00
2024-11-18 BUY 6,732 69.890* 67.92
2024-11-12 BUY 2,324 65.810* 68.02
2024-11-11 BUY 1,577 66.700* 68.09
2024-11-08 BUY 1,190 66.230* 68.19
2024-11-07 BUY 7,387 65.840* 68.33
2024-11-06 BUY 6,128 65.750* 68.49
2024-11-05 BUY 3,306 66.690* 68.75
2024-11-05 BUY 3,306 66.690* 68.75
2024-11-04 BUY 581 66.470* 69.13
2024-11-04 BUY 581 66.470* 69.13
2024-11-01 BUY 1,328 67.540* 69.28
2024-10-31 BUY 336 67.010* 69.50
2024-10-30 BUY 834 68.630* 69.60
2024-10-29 BUY 3,108 69.370* 69.63
2024-10-28 SELL -588 68.520* 70.00 Profit of 41,158 on sale
2024-10-28 SELL -588 68.520* 70.00 Profit of 41,158 on sale
2024-10-25 BUY 1,008 69.380* 70.12
2024-10-24 BUY 672 70.350* 69.97
2024-10-24 BUY 672 70.350* 69.97
2024-10-23 BUY 840 70.610* 69.65
2024-10-22 BUY 4,517 69.240* 70.05
2024-10-21 BUY 2,352 70.050* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-25	BUY	1,148	75.270*	72.94
2025-09-18	BUY	82	74.550*	72.93
2025-09-17	BUY	738	75.200*	72.91
2025-09-11	BUY	410	78.010*	72.88
2025-09-09	BUY	410	79.800*	72.81
2025-07-24	BUY	82	75.800*	72.79
2025-07-23	BUY	492	76.910*	72.77
2025-07-22	BUY	738	76.300*	72.74
2025-07-21	BUY	164	76.560*	72.72
2025-07-18	SELL	-820	76.490*	72.70 Profit of 59,612 on sale
2025-07-17	BUY	82	76.180*	72.68
2025-07-16	BUY	328	76.140*	72.65
2025-07-15	SELL	-1,245	76.810*	72.63 Profit of 90,422 on sale
2025-07-14	BUY	656	78.280*	72.59
2025-07-11	SELL	-164	78.050*	72.56 Profit of 11,899 on sale
2025-07-10	BUY	656	78.800*	72.52
2025-07-09	BUY	656	77.190*	72.49
2025-07-08	BUY	492	76.390*	72.46
2025-07-07	SELL	-1,886	76.690*	72.43 Profit of 136,611 on sale
2025-07-02	SELL	-2,378	77.020*	72.35 Profit of 172,037 on sale
2025-06-30	BUY	1,394	78.210*	72.31
2025-06-27	BUY	738	78.210*	72.27
2025-06-25	SELL	-164	76.970*	72.20 Profit of 11,841 on sale
2025-06-24	BUY	82	75.850*	72.18
2025-06-23	BUY	2,132	75.320*	72.15
2025-06-18	SELL	-492	73.980*	72.13 Profit of 35,487 on sale
2025-06-13	SELL	-246	75.150*	72.08 Profit of 17,731 on sale
2025-06-12	BUY	246	75.890*	72.05
2025-06-11	BUY	328	75.470*	72.03
2025-06-06	SELL	-410	77.520*	71.92 Profit of 29,489 on sale
2025-06-05	SELL	-246	77.770*	71.88 Profit of 17,683 on sale
2025-06-04	SELL	-328	77.850*	71.84 Profit of 23,562 on sale
2025-06-02	BUY	1,066	78.100*	71.74
2025-05-30	SELL	-237	78.220*	71.69 Profit of 16,991 on sale
2025-05-29	BUY	82	77.730*	71.64
2025-05-28	SELL	-81	76.660*	71.60 Profit of 5,800 on sale
2025-05-27	BUY	902	76.220*	71.57
2025-05-23	SELL	-1,640	74.990*	71.51 Profit of 117,281 on sale
2025-05-22	SELL	-1,804	74.790*	71.49 Profit of 128,961 on sale
2025-05-21	BUY	82	76.100*	71.45
2025-05-20	BUY	656	77.830*	71.40
2025-05-19	BUY	2,378	78.040*	71.34
2025-05-16	BUY	2,214	78.000*	71.28
2025-05-15	BUY	1,804	76.880*	71.24
2025-05-14	BUY	1,640	76.750*	71.19
2025-05-13	SELL	-328	75.500*	71.15 Profit of 23,338 on sale
2025-05-12	BUY	82	74.800*	71.12
2025-05-09	BUY	246	73.680*	71.10
2025-05-08	SELL	-2,378	74.630*	71.07 Profit of 168,998 on sale
2025-05-07	SELL	-1,148	75.040*	71.03 Profit of 81,545 on sale
2025-05-06	BUY	2,870	74.920*	71.00
2025-05-02	BUY	246	75.650*	70.92
2025-05-01	SELL	-410	75.180*	70.88 Profit of 29,060 on sale
2025-04-30	BUY	246	75.490*	70.83
2025-04-29	BUY	574	76.280*	70.78
2025-04-28	BUY	1,224	75.540*	70.74
2025-04-25	BUY	1,148	76.040*	70.69
2025-04-24	BUY	328	75.130*	70.64
2025-04-23	BUY	902	70.460*	70.64
2025-04-22	SELL	-498	70.600*	70.65 Profit of 35,181 on sale
2025-04-17	BUY	164	71.530*	70.63
2025-04-16	BUY	7,784	71.200*	70.62
2025-04-15	BUY	1,640	70.760*	70.62
2025-04-11	BUY	2,050	69.400*	70.64
2025-04-10	BUY	3,362	68.260*	70.67
2025-04-09	BUY	656	69.900*	70.67
2025-04-08	BUY	1,722	67.070*	70.71
2025-04-07	BUY	1,964	69.000*	70.73
2025-04-04	SELL	-4,920	69.360*	70.75 Profit of 348,079 on sale
2025-04-02	BUY	574	72.050*	70.73
2025-03-31	SELL	-2,214	72.480*	70.70 Profit of 156,530 on sale
2025-03-28	SELL	-1,394	70.910*	70.70 Profit of 98,552 on sale
2025-03-27	SELL	-410	71.190*	70.69 Profit of 28,984 on sale
2025-03-26	BUY	738	71.090*	70.69
2025-03-25	SELL	-984	71.240*	70.68 Profit of 69,549 on sale
2025-03-24	BUY	574	71.350*	70.67
2025-03-21	BUY	984	70.460*	70.67
2025-03-19	BUY	152	70.900*	70.67
2025-03-18	SELL	-1,476	70.340*	70.67 Profit of 104,313 on sale
2025-03-17	BUY	1,558	70.630*	70.67
2025-03-14	BUY	1,394	69.290*	70.69
2025-03-13	BUY	6,876	67.950*	70.73
2025-03-12	BUY	3,280	68.510*	70.76
2025-03-11	BUY	1,312	68.390*	70.79
2025-03-07	BUY	778	70.330*	70.83
2025-03-06	SELL	-738	71.800*	70.81 Profit of 52,261 on sale
2025-03-05	BUY	2,554	72.850*	70.79
2025-03-04	BUY	492	71.380*	70.78
2025-03-03	BUY	2,214	71.390*	70.77
2025-02-28	SELL	-574	71.620*	70.75 Profit of 40,613 on sale
2025-02-27	BUY	82	71.400*	70.74
2025-02-26	SELL	-164	71.960*	70.73 Profit of 11,599 on sale
2025-02-25	BUY	1,558	71.450*	70.71
2025-02-21	BUY	1,148	73.300*	70.64
2025-02-20	BUY	656	74.710*	70.57
2025-02-19	BUY	164	74.670*	70.50
2025-02-18	BUY	410	75.670*	70.41
2025-02-13	BUY	1,394	76.000*	70.10
2025-02-12	BUY	492	75.820*	69.99
2025-02-11	SELL	-164	70.910*	69.98 Profit of 11,476 on sale
2025-02-07	SELL	-656	70.350*	69.95 Profit of 45,885 on sale
2025-02-06	BUY	328	70.990*	69.93
2025-02-04	BUY	2,870	71.330*	69.85
2025-02-03	BUY	1,066	71.380*	69.82
2025-01-31	BUY	246	72.450*	69.76
2025-01-30	BUY	164	73.220*	69.69
2025-01-29	BUY	1,558	71.130*	69.65
2025-01-28	BUY	738	72.560*	69.58
2025-01-27	BUY	1,148	69.200*	69.59
2025-01-24	BUY	738	68.990*	69.61
2025-01-23	BUY	2,132	68.930*	69.63
2025-01-02	BUY	2,673	72.590*	69.55
2024-12-30	SELL	-7,630	74.240*	69.43 Profit of 529,723 on sale
2024-12-10	BUY	588	73.390*	69.32
2024-12-09	BUY	672	70.900*	69.28
2024-12-06	BUY	1,008	71.530*	69.21
2024-12-05	BUY	252	72.430*	69.12
2024-12-04	BUY	924	74.200*	68.96
2024-12-03	BUY	2,964	70.200*	68.92
2024-12-02	BUY	247	70.530*	68.87
2024-11-29	BUY	1,909	71.350*	68.79
2024-11-27	BUY	2,241	72.070*	68.55
2024-11-26	BUY	4,814	71.550*	68.44
2024-11-25	BUY	4,980	71.270*	68.33
2024-11-22	BUY	5,880	70.480*	68.25
2024-11-21	BUY	924	70.380*	68.16
2024-11-20	BUY	840	69.540*	68.10
2024-11-19	BUY	756	70.200*	68.00
2024-11-18	BUY	6,732	69.890*	67.92
2024-11-12	BUY	2,324	65.810*	68.02
2024-11-11	BUY	1,577	66.700*	68.09
2024-11-08	BUY	1,190	66.230*	68.19
2024-11-07	BUY	7,387	65.840*	68.33
2024-11-06	BUY	6,128	65.750*	68.49
2024-11-05	BUY	3,306	66.690*	68.75
2024-11-05	BUY	3,306	66.690*	68.75
2024-11-04	BUY	581	66.470*	69.13
2024-11-04	BUY	581	66.470*	69.13
2024-11-01	BUY	1,328	67.540*	69.28
2024-10-31	BUY	336	67.010*	69.50
2024-10-30	BUY	834	68.630*	69.60
2024-10-29	BUY	3,108	69.370*	69.63
2024-10-28	SELL	-588	68.520*	70.00 Profit of 41,158 on sale
2024-10-28	SELL	-588	68.520*	70.00 Profit of 41,158 on sale
2024-10-25	BUY	1,008	69.380*	70.12
2024-10-24	BUY	672	70.350*	69.97
2024-10-24	BUY	672	70.350*	69.97
2024-10-23	BUY	840	70.610*	69.65
2024-10-22	BUY	4,517	69.240*	70.05
2024-10-21	BUY	2,352	70.050*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	406,402	0	1,881,727	21.6%
2025-09-18	684,520	1,177	3,487,981	19.6%
2025-09-17	484,322	210	1,603,065	30.2%
2025-09-16	811,953	856	2,055,937	39.5%
2025-09-15	611,012	104	1,391,882	43.9%
2025-09-12	982,928	1,100	2,234,227	44.0%
2025-09-11	514,234	828	1,919,009	26.8%
2025-09-10	669,705	149	1,567,941	42.7%
2025-09-09	441,493	0	925,375	47.7%
2025-09-08	632,587	672	1,251,939	50.5%
2025-09-05	334,037	300	934,006	35.8%
2025-09-04	380,318	0	871,931	43.6%
2025-09-03	701,943	459	1,170,966	59.9%
2025-09-02	397,396	53	1,208,872	32.9%
2025-08-29	397,628	800	844,318	47.1%
2025-08-28	604,087	4	1,056,653	57.2%
2025-08-27	493,608	822	875,886	56.4%
2025-08-26	480,268	0	868,213	55.3%
2025-08-25	796,556	0	1,181,258	67.4%
2025-08-22	552,739	1	1,011,678	54.6%
2025-08-21	873,044	798	1,597,742	54.6%
2025-08-20	847,847	38,699	1,560,105	54.3%
2025-08-19	613,349	33	1,256,577	48.8%
2025-08-18	668,719	439	1,642,759	40.7%
2025-08-15	369,455	513	826,723	44.7%
2025-08-14	514,202	6,112	864,593	59.5%
2025-08-13	567,857	299	1,347,264	42.1%
2025-08-12	547,773	12,316	1,428,277	38.4%
2025-08-11	487,823	0	1,152,630	42.3%
2025-08-08	661,697	20	1,224,458	54.0%
2025-08-07	669,931	982	1,297,469	51.6%
2025-08-06	880,028	413	1,551,659	56.7%
2025-08-05	661,933	8	1,592,649	41.6%
2025-08-04	572,165	268	1,310,044	43.7%
2025-08-01	678,028	5,600	1,308,863	51.8%
2025-07-31	831,401	249	1,817,975	45.7%
2025-07-30	1,305,016	693	2,481,808	52.6%
2025-07-29	1,129,154	58	2,399,223	47.1%
2025-07-28	684,101	2,111	2,276,892	30.0%
2025-07-25	1,669,752	920	6,616,259	25.2%
2025-07-24	455,593	0	2,607,898	17.5%
2025-07-23	444,645	0	1,978,110	22.5%
2025-07-22	447,883	511	2,702,925	16.6%
2025-07-21	568,293	27	1,249,727	45.5%
2025-07-18	590,448	59	2,118,402	27.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CSPXx(MXN) CXE